Specialty / Expertise

Gastrointestinal cancers

Research Interests

Current Research Projects

Research Staff

Training

Dr. Lin received his MD from China Medical University, Shenyang, China. He completed his Internal Medicine Residency at Brown University, Providence, RI. He was a Post-Doctoral Fellow in Hematology/Oncology at Beth Isreal Deconess Medical Center, Harvard Medical School, Boston, MA.

Selected Publications:

Yang DJ, Bryant J, Chang JY, Mendez R, Oh CS, Yu DF, Ito M, Azhdarinia A, Kohanim S, Kim EE, Lin E, Podoloff DA. Assessment of cyclooxygense-2 expression with Tc-99m-labeled Celebrex. Anti-Cancer Drugs 2004 15(3):255-263.

Crane CH, Skibber JM, Birnbaum EH, Feig BW, Singh AK, Delclos ME, Lin EH, Fleshman JW, Thames HD, Kodner IJ, Lockett MA, Picus J, Phan T, Chandra A, Janjan NA, Read TE, Myerson RJ. The addition of continuous infusion 5FU to preoperative radiotherapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiation Oncol Biol Phys 2003 57:84-89.

Peng Z, Zhang F, Zhou C, Ling Y, Bai S, Liu W, Qiu G, He L, Wang L, Wei D, Lin E, Xie K. Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer. Int J Gastrointest Cancer 2003 34(1):39-48.

Lin E, Morris J, Moyer G. Celecoxib attenuate capecitabine induced hand and foot syndrome and diarrhea and may improve time to tumor progression and overall survival in patients with metastatic colorectal cancer. Oncology 2002 16(14):31-37 suppl.

Bonnen M. Crane C. Vauthey JN. Skibber J. Delcos ME. Rodriguez-Bigas M. Hoff PM. Lin E. Eng C. Wong A. Janjan NA. Feig BW. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiation Oncol Biol Phys 2004 60(4):1098-1105.

Xiong HQ. Abbruzzese JL. Lin E. Wang L. Zheng L. Xie K. NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells. Intl J Cancer 2004 108(2):181-188.